Daniele Avenoso

19PUBLICATIONS
99CO-AUTHORS
Medical bacteriologyHaematologyCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Geriatrics and gerontology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 02, 2026
Fluoroquinolone-Free Prophylaxis and Impact on Bacterial Infections, Resistance, and Survival in Allo-HSCT: 5-Year Follow-up of the BATMO Protocol (Best Anti-microbical Therapy Trapianto di Midollo Osseo).

|Aug 22, 2026
Mitigating HLA Disparity in AML Transplantation: Comparable Outcomes After Haploidentical and 9/10 Mismatched Unrelated Donor Transplantation With Treosulfan and PTCy.

|Jun 26, 2026
Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. Cancers 2025, 17, 3278.

|Jun 24, 2026
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission.

|Oct 29, 2025
Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50.

Eugenia Accorsi Buttini, Alberto Zucchelli, Paolo Tura

|Sep 19, 2024
Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy.

Andrew J Innes, Chloe Hayden, Victoria Orovboni

Pageof 4

Frequent Collaborators

7 joint publications

Michele Malagola

7 joint publications

Nicola Polverelli

5 joint publications

Mirko Farina

4 joint publications

Massimo Martino